Faecal concentrations of piperacillin and tazobactam in elderly patients -: J Antimicrob Chemother 2001;: 48:155-156

被引：9

作者：

Wilcox, MH ^{[1
]}

Brown, A

Freeman, J

机构：

[1] Univ Leeds, Dept Microbiol, Leeds LS2 9JT, W Yorkshire, England

[2] Gen Infirm, Leeds LS2 9JT, W Yorkshire, England

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2001年 / 48卷 / 01期

关键词：

D O I：

10.1093/jac/48.1.155

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：155 / 156

页数：2

共 6 条

[1]

ANAND A, 1994, AM J GASTROENTEROL, V89, P519

[2] 3RD-GENERATION CEPHALOSPORINS AS A RISK FACTOR FOR CLOSTRIDIUM-DIFFICILE-ASSOCIATED DISEASE - A 4-YEAR SURVEY IN A GENERAL-HOSPITAL [J].

DELALLA, F ;

PRIVITERA, G ;

ORTISI, G ;

RIZZARDINI, G ;

SANTORO, D ;

PAGANO, A ;

RINALDI, E ;

SCARPELLINI, P .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 (04) :623-631

[3] COLONIZATION RESISTANCE OF THE HUMAN INTESTINAL MICROFLORA - TESTING THE HYPOTHESIS IN NORMAL VOLUNTEERS [J].

GORBACH, SL ;

BARZA, M ;

GIULIANO, M ;

JACOBUS, NV .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1988, 7 (01) :98-102

[4] EFFECT OF PIPERACILLIN TAZOBACTAM TREATMENT ON HUMAN BOWEL MICROFLORA [J].

NORD, CE ;

BRISMAR, B ;

KASHOLMTENGVE, B ;

TUNEVALL, G .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 31 :61-65

[5]

Settle CD, 1998, ALIMENT PHARM THER, V12, P1217

[6]

SORGEL F, 1993, J ANTIMICROBIAL C SA, V23, P39

← 1 →